

GENERAL INFORMATION
CONGRESS DATES / IMPORTANT DATES / INVOICE & CANCELLATION / VENUE / ABOUT HUNGARY / TRAVEL TO SIÓFOK / ABOUT SIÓFOK
KEY TOPICS OF THE CONGRESS

Pharmaceutical Chemistry and Pharmacology
This topic focuses on the discovery and development of small molecules and biopharmaceuticals, including the identification of novel drug targets and innovative drug candidates. Emphasis is placed on identification of novel targets, drug repurposing, advanced therapeutics, green chemistry, pharmacognosy, biotechnology, and AI-driven drug development and toxicology prediction as efficient and sustainable routes to therapeutic innovation.

Pharmaceutical Technology and Drug Delivery
This area addresses how advanced formulation science translates chemical and biological discoveries into effective therapies. Topics include preformulation, particle engineering, nano- and amorphous systems, advanced crystallization techniques, alternative and vaccine delivery approaches, and climatic stability challenges. Special attention is given to vaccines, pulmonary delivery, veterinary medicines, user-friendly oral dosage forms, and medical devices, highlighting the need for patient-centered and application-oriented pharmaceutical design. Emerging fields such as precision pharmaceutics, 3D printing technologies, sustainable and continuous manufacturing, virtual formulation development, and AI-assisted digital twins underscore the growing role of data integration and digitalization in modern pharmaceutical technology.

Clinical and Hospital Pharmacy
Clinical and hospital pharmacy emphasizes the safe, effective, and individualized use of medicines in real healthcare settings. Key areas include therapeutic drug monitoring, pharmacogenomics, pharmacovigilance, and the integration of clinical trial data with real-world evidence. This topic reflects the commitment of the conference to personalized and precision medicine, ensuring that pharmaceutical innovation leads to measurable improvements in patient outcomes.

New Directions in Clinical Research
This topic highlights the transformation of clinical research through real-world evidence, data-driven methodologies, and digital health technologies. AI-assisted trial design and monitoring, along with integrated health data sources, enable more adaptive, efficient, and patient-relevant studies. The focus is on therapy optimization and outcome-based evaluation, supporting a shift from protocol-driven research toward learning healthcare systems.

Pharmaceutical Analytics and Modeling
Pharmaceutical analytics and modeling provide the quantitative foundation for quality, safety, and efficacy throughout the drug lifecycle. Core themes include the analysis of contaminants and impurities, in vitro dissolution and permeation evaluation, process analytical technology (PAT), biorecognition systems, and metabolism modeling. These tools are essential for understanding complex pharmaceutical systems and for supporting data-driven decision-making in both development and clinical application.

Industrial Pharmacy
Industrial pharmacy addresses the translation of scientific innovation into scalable, regulated, and globally accessible pharmaceutical products. Topics include market and innovation trends, safety and efficacy considerations, packaging and logistics, and regulatory affairs and compliance. The balance between globalization, decentralization and localization reflects the need to maintain international quality standards, while responding to local healthcare, regulatory, and sustainability requirements.
SMARTER MEDICINE – BETTER CARE
From Innovation to Therapy: Science, Quality, and Patient Care in the Pharmaceutical Sciences
The 11th BBBB International Conference focuses on the translation of pharmaceutical innovation into safe, effective, and patient-centered therapies. It spans the full spectrum of pharmaceutical sciences, from drug discovery and advanced formulation technologies to clinical application and real-world evidence. Special emphasis is placed on precision medicine, data-driven and AI-supported research, and innovative drug delivery solutions. Clinical and hospital pharmacy are highlighted as key interfaces between research and patient care. Sustainability, quality, and regulatory robustness are treated as integral components of innovation. The Conference aims to foster interdisciplinary collaboration between academia, healthcare, industry, and regulatory stakeholders in support of better patient outcomes.
Based on the thematic areas outlined below, we warmly invite and encourage the submission of abstracts for both oral and poster presentations. The following topics reflect the scientific scope of the conference and highlight key areas where innovative research, technological advancement, and patient-centered pharmaceutical practice are especially welcome.
SPEAKERS OF THE THE CONGRESS


ACCREDITATION
The congress will be accredited for Hungarian participants.
PLENARY AND KEYNOTE LECTURES
PLENARY LECTURES
Nanomedicine for RNA delivery: towards precision medicine?
Giuseppe De Rosa, PhD
President of EUFEPS
Professor of Pharmaceutical Technology Department of Pharmacy University of Naples Federico II
Advanced Drug Delivery Systems for Brain Repair and Neurorestoration
Prof. María J. Blanco-Prieto
Past President of EUFEPS
Full Professor
University of Navarra, Spain
Digitalization in the Pharma industry: opportunity or challenge?
Dr. Zoltán Finta
Head of Digitalization, Industrial Operation Euroapi
Development of a health industry innovation ecosystem through university and corporate collaboration
Dr. Balázs Lendvai
Head of Department of Pharmacology and Drug Safety
Richter Gedeon Plc.
Nucleoside-modified mRNA: the past, present and future
Dr. Norbert Pardi
Associate Professor
Department of Microbiology of the Perelman School of Medicine, Pennsylvania
Silicone-Based Transdermal Patch Development: Translating Academic Innovation into Preclinical Reality
Dr. Erika Pintér MD; PhD; DSc; FBPhS
Head of Department
Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Pecs, Hungary
Seeing with many eyes: a shared vision for medication stewardship
Dr. András Süle
Director of Pharmacy at the Péterfy Hospital and Outpatient Clinic, Budapest, Hungary
KEYNOTE LECTURES
Behind the numbers: new focus in drug utilisation (qualitative studies)
Dr. Ria Benkő
Associate Professor, University of Szeged, Institute of Clinical Pharmacy
2- 3D and 4D printing as promising technologies for innovative and personalized pharmaceuticals for cancer
Prof. Dr. Erem Bilensoy
Full professor, head of department
Pharmaceutical Technology at Hacettepe University Faculty of Pharmacy, Turkey
Linking Pharmacotherapy and the ‘Digital World’: Opportunities, Obstacles, and Clinical Impact
Zelma Faisal, PharmD, PhD
Clinical Pharmacist, Institute of Clinical Pharmacy, University of Pécs
Managing Medication Safety : Evidence from Hospitals and Community Care
PhD. Anna-Riia Holmström
Associate Professor in Medication Safety and Effectiveness
Faculty of Pharmacy, University of Helsinki
Trends and perspectives in therapeutic drug monitoring
Dr. Gellért Karvaly
Department of Laboratory Medicine, Semmelweis University
Discovery of Caspase-1 and Caspase-6 Targeted Small Molecules for Neuroinflammation and Neurodegeneration
Assoc. Prof. Dr. Damijan Knez
Assistant professor and researcher
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Slovenia
Testing Antimicrobial Activity of Electrospun Nanofibers:
From Standard Assays to Tailored Methods
Dr. Liis Preem
Research fellow and lecturer
Institute of Pharmacy, University of Tartu, Estonia
Preclinical characterization of novel antimicrobial materials from
laboratory to living systems
Dr. Kelli Randmäe
PhD candidate in Pharmacy at the Institute of Pharmacy, University of Tartu
Inkjet Printing in Personalised Drug Delivery: Ink Formulation Stability Improvement via a Dry Preformulation Approach
Dr. Barbara Sterle Zorec
Assistant Professor of Pharmaceutical Technology at the Faculty of Pharmacy
University of Ljubljana
AI-based prediction and prevention of drug adverse effects by real world data: focus on anticoagulation
Dr. Tiihonen Miia
Associate Professor, Head of Clinical Pharmacy
University of Eastern Finland
New OINDPs Guidelines – Reality vs. Regulatory Expectations
Assoc. Dr. Ayca Yıldız-Peköz (PhD. Pharm)
Professor of Pharmaceutical Technology
Istanbul University, Turkey
SCIENTIFIC AND ORGANIZING COMMITTEES
INTERNATIONAL SCIENTIFIC COMMITTEE
Chair of the Committee:
Prof. Ildikó Bácskay
University of Debrecen, Hungary
Members:
Prof. Nevin Çelebi
Başkent University, Turkey
Dr. Anna Galkin
University of Helsinki, Finland
Prof. Karin Kogermann
University of Tartu, Estonia
Prof. György Marosi
Budapest University of Technology and Economics, Hungary
Prof. Aleš Obreza
University of Ljubljana, Slovenia
Dr. Liis Preem
University of Tartu, Estonia
Prof. Jarkko Rautio
University of Eastern Finland, Finland
Prof. Selma Sahin
Hacettepe University, Turkey
Prof. Alenka Zvonar Pobirk
University of Ljubljana, Slovenia
ORGANIZING COMMITTEE
Conference Chair:
Prof. Lajos Botz
Chair of the International Scientific Committee:
Prof. Ildikó Bácskay
Secretary General of the Conference:
Prof. Tamás Tábi
Members:
Dr. János Gyimesi
Dr. Erzsébet Háznagy-Radnai
Dr. Ilona Higyisán
Dr. Attila Marosi
Prof. György Marosi
Prof. Éva Szökő
Dr. Attila Szűcs